CONCLUSION: brimonidine made domestically is effective and safe in reducing IOP of POAG and OHT, possessing equivalent efficacy with brimonidine imported.
结论：国产溴莫尼定滴眼液对于控制原发性开角型青光眼和高眼压症的眼压是有效和安全的，效果与进口制剂相当。
AIM: To investigate the therapeutic value of domestic brimonidine in treating patients with primary open Angle glaucoma (POAG) or ocular hypertension (OHT).
目的：验证国产溴莫尼定滴眼液治疗原发性开角型青光眼和高眼压症的治疗价值。
ObjectiveTo compare the effects of two antiglaucoma drugs( levobunlol and brimonidine) on cultured human non-pigment ciliary epithelial (NPE) cells and evaluate the safety of the two drugs.
目的体外培养人无色素睫状上皮（NPE）细胞，比较抗青光眼药物贝他根与阿法根对NPE细胞增殖的影响，评估两种药物使用的安全性。
ObjectiveTo compare the effects of two antiglaucoma drugs( levobunlol and brimonidine) on cultured human non-pigment ciliary epithelial (NPE) cells and evaluate the safety of the two drugs.
目的体外培养人无色素睫状上皮（NPE）细胞，比较抗青光眼药物贝他根与阿法根对NPE细胞增殖的影响，评估两种药物使用的安全性。
应用推荐